Browse our GLP-1 weight loss injections, including Mounjaro (tirzepatide). Each treatment has its own page and eligibility check, a prescriber decides what's suitable after a full assessment.
Tap a treatment to see full details, pricing by dose, and to check your eligibility. These aren't add-to-basket products, every one goes through assessment and prescriber review.
The order is never the first step, the assessment is. A prescriber reviews every request and issues treatment only if it's suitable.
Read its page and run the quick eligibility check.
Medical questions plus identity and weight verification.
A UK-registered prescriber prescribes only if suitable.
Pharmacist-checked, delivered, with ongoing care.
In short: weight loss injections are prescription-only medicines, usually GLP-1 based, given as a once-weekly injection. They mimic gut hormones that reduce appetite, so you feel fuller for longer and tend to eat less. In the UK they can only be supplied after a prescriber confirms they're suitable for you, which is why every PharmaRoo treatment starts with an eligibility check and a full assessment, never an add-to-basket.
The GLP-1 medicines people compare most often, and how they differ on mechanism, format and UK licensing status.
This comparison is general information, not a recommendation or an offer to supply. Which medicine, if any, is appropriate is a decision for your prescriber after a full assessment.
Weight loss injections are prescription-only medicines, usually GLP-1 based, given once weekly. They mimic gut hormones that reduce appetite and slow how quickly the stomach empties, so you feel fuller for longer and tend to eat less. In the UK they can only be supplied after a prescriber confirms they're suitable for you.
Mounjaro (tirzepatide) acts on two hormone pathways, GLP-1 and GIP. Wegovy and Ozempic are both semaglutide and act on one (GLP-1). Mounjaro and Wegovy are licensed in the UK for weight management; Ozempic is licensed for type 2 diabetes, not weight loss.
They're usually considered at a BMI of 30 or above, or 27 or above alongside a weight-related condition such as type 2 diabetes, high blood pressure or sleep apnoea. A prescriber confirms eligibility after a full assessment, including identity and weight verification, not on a questionnaire alone.
No. They're prescription-only medicines, so they can't be sold over the counter or selected on demand. A prescriber assesses you and sets the dose, and patients start at the lowest strength and step up gradually.